Browsing Tag
ImClone Systems
1 post
How Celltrion’s $330m Eli Lilly deal positions it for a new era of U.S. biomanufacturing
Celltrion’s $330M purchase of Eli Lilly’s U.S. plant signals a tariff-proof pivot in biosimilars, reshaping pharma manufacturing in the U.S. today.